Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003100665 | SCV003484212 | likely benign | Nemaline myopathy 2 | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003084930 | SCV003666884 | uncertain significance | Inborn genetic diseases | 2022-12-16 | criteria provided, single submitter | clinical testing | The c.16064A>G (p.D5355G) alteration is located in exon 114 (coding exon 112) of the NEB gene. This alteration results from a A to G substitution at nucleotide position 16064, causing the aspartic acid (D) at amino acid position 5355 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |